Skip to main content

Advertisement

Log in

Hypoglycemia as a Driver of Cardiovascular Risk in Diabetes

  • Clinical Trials and Their Interpretations (J Plutzky, Section Editor)
  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

Abstract

Severe hypoglycemia in patients with diabetes is associated with increased risk of adverse cardiovascular events and death. Recent large randomized clinical trials in individuals with type 2 diabetes have shown that intensive glycemic control may result in increased mortality, and hypoglycemia has been investigated as a possible cause. Acute hypoglycemia is a proarrhythmic, proinflammatory, and prothrombotic state, and several mechanisms have been proposed to explain how hypoglycemia might increase cardiovascular morbidity and mortality. However, data from large clinical trials do not provide strong evidence to establish hypoglycemia as a cause of increased mortality. Severe hypoglycemia is also a marker of frailty and a predictor of adverse outcomes in patients with diabetes. Individualized therapy should be the goal in patients with diabetes to avoid severe hypoglycemia and any related adverse outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Riddle MC. Glycemic control and cardiovascular mortality. Curr Opin Endocrinol Diabetes Obes. 2011;18(2):104–9.

    Article  PubMed  CAS  Google Scholar 

  2. Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545–59.

    Article  PubMed  CAS  Google Scholar 

  3. Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560–72.

    Article  PubMed  CAS  Google Scholar 

  4. Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360(2):129–39.

    Article  PubMed  CAS  Google Scholar 

  5. Finfer S, Blair D, Bellomo R, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283–97.

    Article  PubMed  Google Scholar 

  6. Riddle MC. Counterpoint: intensive glucose control and mortality in ACCORD-still looking for clues. Diabetes Care. 2010;33(12):2722–4.

    Article  PubMed  Google Scholar 

  7. • Gerstein HC, Miller ME, Genuth S, et al. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med. 2011;364(9):818–28. This report describes the 5-year outcomes for mortality and cardiovascular events in participants in the ACCORD trial.

    Article  PubMed  CAS  Google Scholar 

  8. • Bonds DE, Miller ME, Bergenstal RM, et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. Br Med J. 2010;340:b4909. Post hoc analysis of the ACCORD study suggests that severe hypoglycemia was likely not the cause of the difference in mortality between the intensive treatment and control arms.

    Article  Google Scholar 

  9. • Seaquist ER, Miller ME, Bonds DE, et al. The impact of frequent and unrecognized hypoglycemia on mortality in the ACCORD study. Diabetes Care. 2012;35(2):409–14. This post hoc analysis of the ACCORD study showed that subjects in the intensive control group who experienced more episodes of hypoglycemia had a lower risk of death. One explanation for this interesting finding is that individuals with diabetes who are exposed to frequent hypoglycemia can develop a blunted counterregulatory response to hypoglycemia which could reduce impact of hypoglycemia on cardiovascular function.

    Article  PubMed  CAS  Google Scholar 

  10. Zoungas S, Patel A, Chalmers J, et al. Severe hypoglycemia and risks of vascular events and death. N Engl J Med. 2010;363(15):1410–8. This retrospective analysis of the ADVANCE study showed severe hypoglycemia was associated with increased risks of cardiovascular events and death.

    Article  PubMed  CAS  Google Scholar 

  11. Skyler JS, Bergenstal R, Bonow RO, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association (vol 32, pg 187, 2009). Diabetes Care. 2009;32(4):754.

    Google Scholar 

  12. Johnston SS, Conner C, Aagren M, et al. Evidence linking hypoglycemic events to an increased risk of acute cardiovascular events in patients with type 2 diabetes. Diabetes Care. 2011;34(5):1164–70.

    Article  PubMed  Google Scholar 

  13. McCoy RG, Van Houten HK, Ziegenfuss JY, et al. Increased mortality of patients with diabetes reporting severe hypoglycemia. Diabetes Care. 2012;35(9):1897–901.

    Article  PubMed  Google Scholar 

  14. Hsu P, Sung S, Cheng H, et al. Association of clinical symptomatic hypoglycemia with cardiovascular events and total mortality in type 2 diabetes: a nationwide population-based study. Diabetes Care. 2013;36(4):894–900.

    Article  PubMed  Google Scholar 

  15. Zhao Y, Campbell CR, Fonseca V, Shi L. Impact of hypoglycemia associated with antihyperglycemic medications on vascular risks in veterans with type 2 diabetes. Diabetes Care. 2012;35(5):1126–32.

    Article  PubMed  Google Scholar 

  16. Gruden G, Barutta F, Chaturvedi N, et al. Severe hypoglycemia and cardiovascular disease incidence in type 1 diabetes the EURODIAB prospective complications study. Diabetes Care. 2012;35(7):1598–604.

    Article  PubMed  CAS  Google Scholar 

  17. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359–67.

    Article  PubMed  Google Scholar 

  18. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354(5):449–61.

    Article  PubMed  Google Scholar 

  19. Soylemez Wiener R, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults—a meta-analysis. JAMA. 2008;300(8):933–44.

    Article  Google Scholar 

  20. Svensson A, McGuire D, Abrahamsson P, Dellborg M. Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J. 2005;26(13):1255–61.

    Article  PubMed  Google Scholar 

  21. Kagansky N, Levy S, Rimon E, et al. Hypoglycemia as a predictor of mortality in hospitalized elderly patients. Arch Intern Med. 2003;163(15):1825–9.

    Article  PubMed  Google Scholar 

  22. Boucai L, Southern WN, Zonszein J. Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities. Am J Med. 2011;124(11):1028–35.

    Article  PubMed  CAS  Google Scholar 

  23. Landstedt-Hallin L, Englund A, Adamson U, Lins P. Increased QT dispersion during hypoglycaemia in patients with type 2 diabetes mellitus. J Intern Med. 1999;246(3):299–307.

    Article  PubMed  CAS  Google Scholar 

  24. • Frier BM, Schernthaner G, Heller SR. Hypoglycemia and cardiovascular risks. Diabetes Care. 2011;34:S132–7. This is a review article on the effects of hypoglycemia on the cardiovascular system.

    Article  PubMed  Google Scholar 

  25. Robinson R, Harris N, Ireland R, Lee S, Newman C, Heller S. Mechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia. Diabetes. 2003;52(6):1469–74.

    Article  PubMed  CAS  Google Scholar 

  26. Desouza C, Salazar H, Cheong B, et al. Association of hypoglycemia and cardiac ischemia—a study based on continuous monitoring. Diabetes Care. 2003;26(5):1485–9.

    Article  PubMed  Google Scholar 

  27. Gerritsen J, Dekker J, TenVoorde B, et al. Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease—the Hoorn study. Diabetes Care. 2001;24(10):1793–8.

    Article  PubMed  CAS  Google Scholar 

  28. Maser R, Mitchell B, Vinik A, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes—a meta-analysis. Diabetes Care. 2003;26(6):1895–901.

    Article  PubMed  Google Scholar 

  29. Cryer P. Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes. 2005;54(12):3592–601.

    Article  PubMed  CAS  Google Scholar 

  30. Davis S, Galassetti P, Wasserman D, Tate D. Effects of antecedent hypoglycemia on subsequent counterregulatory responses to exercise. Diabetes. 2000;49(1):73–81.

    Article  PubMed  CAS  Google Scholar 

  31. Adler GK, Bonyhay I, Fainng H, et al. Antecedent hypoglycemia impairs autonomic cardiovascular function implications for rigorous glycemic control. Diabetes. 2009;58(2):360–6.

    Article  PubMed  CAS  Google Scholar 

  32. Wright RJ, Newby DE, Stirling D, et al. Effects of acute insulin-induced hypoglycemia on indices of inflammation putative mechanism for aggravating vascular disease in diabetes. Diabetes Care. 2010;33(7):1591–7.

    Article  PubMed  CAS  Google Scholar 

  33. Joy NG, Hedrington MS, Briscoe VJ, et al. Effects of acute hypoglycemia on inflammatory and pro-atherothrombotic biomarkers in individuals with type 1 diabetes and healthy individuals. Diabetes Care. 2010;33(7):1529–35.

    Article  CAS  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

A. Moheet declared no conflict of interest. E.R. Seaquist serves/has served as a consultant for AMG Medical, SkyePharma, Merck, and Sanofi-Aventis and is the PI on a grant from Lilly within the last three years.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amir Moheet.

Additional information

This article is part of the Topical Collection on Clinical Trials and Their Interpretations

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moheet, A., Seaquist, E.R. Hypoglycemia as a Driver of Cardiovascular Risk in Diabetes. Curr Atheroscler Rep 15, 351 (2013). https://doi.org/10.1007/s11883-013-0351-7

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11883-013-0351-7

Keywords

Navigation